Aaron Cowen’s AC Immune ACIU Stock Holding History

Aaron Cowen’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-963,500	Closed	-$6.46M	–	97
2021 Q3	$6.46M	Buy	+963,500	New	+$6.9M	0.11%	75

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aaron Cowen's ACIU Position: Q4 2021 in Review

Aaron Cowen sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 963,500 shares — an estimated $6.46M sold.

Aaron Cowen first reported a position in ACIU in Q3 2021 and held it in 1 quarter. The position peaked at $6.46M in Q3 2021. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

Aaron Cowen reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
Aaron Cowen sold 963,500 AC Immune shares in Q4 2021, an estimated $6.46M.
Aaron Cowen first reported a position in AC Immune in Q3 2021 and held it in 1 quarter.
Aaron Cowen's AC Immune position peaked at $6.46M in Q3 2021.
44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.